FUREN Group Pharmaceutical Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares FUREN Group Pharmaceutical Co Ltd with three other
companies in this sector in China:
KPC Pharmaceuticals Inc
sales of 5.85 billion Chinese Renmimbi [US$852.85 million]
of which 43%
was Drugs Wholesale and Retail),
Tianjin Zhong Xin Pharmaceutical Group Corporation Limited
(5.69 billion Chinese Renmimbi [US$829.09 million]
of which 64%
was Chinese Medicine), and
Zhejiang Medicine Co., Ltd.
(5.69 billion Chinese Renmimbi [US$829.58 million]
of which 43%
was Life Nourishment).
Sales increased substantially in 2017:
FUREN Group Pharmaceutical Co Ltd reported sales of 5.80 billion Chinese Renmimbi (US$845.22 million)
December of 2017.
increase of 1,070.2%
versus 2016, when the company's sales were 495.63 million Chinese Renmimbi.
Sales at FUREN Group Pharmaceutical Co Ltd have increased during each of the previous five years
(and since 2012, sales have increased a total of 1,570%).
Sales of Pharmaceutical Business saw an increase
that was more than double the company's growth rate: sales were up
3,215.1% in 2017, from
25.52 million Chinese Renmimbi to 846.00 million Chinese Renmimbi.